Solid Tumors Clinical Trials

A listing of 43 Solid Tumors clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Solid Tumors

1 - 12 of 43

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 43 active clinical trials seeking participants for Solid Tumors research studies. The states with the highest number of trials for Solid Tumors participants are Texas, California, New York and Florida.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Study

Recruiting

Are you tired of living with chronic cough? The ASPIRE Study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough. You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you.

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Allergic Asthma

Learn More

Featured Trial

Studying an Investigational Virus Vaccine

Recruiting

The main objectives of this study are to assess the safety and effectiveness of an investigational vaccine aimed at preventing norovirus, commonly known as the stomach flu. Participants will be randomly assigned to receive either the investigational vaccine or a placebo. Should you express interest, you will be contacted directly by the research site, which will provide further details and answer any questions you may have about study requirements, risks/benefits, and any compensation.

Conditions:

Healthy

Interested in vaccine studies

All Conditions

Preventative Trials

Learn More

Featured Trial

Type 2 Diabetes Clinical Trial

Recruiting

Can changing your breakfast improve your type 2 diabetes? If you have an HbA1C of 7.0% or higher, you are invited to participate in an online study at the University of Michigan.

Conditions:

Type 2 Diabetes

Diabetes Mellitus Type 2 in Obese

Diabetes Type Two

Type 2 Diabetes Mellitus

Diabete Type 2

Learn More

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06179160

Recruiting

This study is conducted to determine the safety and tolerability of INCB161734 as a single agent or in combination with other anticancer therapies.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: Mayo Clinic Hospital, Phoenix, Arizona +31 locations

Mayo Clinic Hospital, Phoenix, Arizona

Stanford University, Palo Alto, California

UCLA Healthcare Hematology-Oncology, Santa Monica, California

Sarah Cannon Research Institue At Healthone, Denver, Colorado

Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore, Maryland

Dana Farber Cancer Institute, Boston, Massachusetts

Hackensack University Medical Center, Hackensack, New Jersey

Weill Cornell Medicine, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Scri Oncology Partners - Nashville, Nashville, Tennessee

Md Anderson Cancer Center, Houston, Texas

Chris Obrien Lifehouse, Camperdown, New South Wales

St Vincent'S Hospital Sydney, Darlinghurst, New South Wales

The Alfred Hospital, Melbourne, Victoria

Peter Maccallum Cancer Centre, North Melbourne, Victoria

Linear Clinical Research, Nedlands, Western Australia

Cliniques Universitaires Ucl Saint-Luc, Brussels, Not set

Universitair Ziekenhuis Antwerpen (Uza), Edegem, Not set

Universitair Ziekenhuis (Uz) Leuven, Leuven, Not set

The Ottawa Hospital Cancer Center, Ottawa, Ontario

Princess Margaret Cancer Center, Toronto, Ontario

Centre Leon Berard, Lyon, Not set

Universitaire Du Cancer de Toulouse Institut Claudius Regaud Iuct-Oncopole, Toulouse, Not set

Institut Gustave Roussy, Villejuif Cedex, Not set

Fondazione Irccs Istituto Nazionale Dei Tumori, Milan, Not set

Irccs Istituto Clinico Humanitas, Rozzano, Not set

Centro Ricerche Cliniche Di Verona, Verona, Not set

National Cancer Center Hospital East, Chiba, Not set

The Cancer Institute Hospital of Jfcr, Koto-ku, Not set

Hospital General Universitario Vall D Hebron, Barcelona, Not set

Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario Quironsalud Madrid, Madrid, Not set

Conditions: Solid Tumors

Learn More ›

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

NCT05325866

Recruiting

The primary objectives of this study are to observe the safety and tolerability of bemarituzumab and to evaluate preliminary antitumor activity.

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

04/16/2025

Locations: City of Hope National Medical Center, Duarte, California +114 locations

City of Hope National Medical Center, Duarte, California

University of California Irvine, Orange, California

Rocky Mountain Cancer Centers, Aurora, Colorado

Community Health Network MD Anderson Cancer Center - North, Indianapolis, Indiana

Henry Ford Hospital, Detroit, Michigan

United States Oncology Regulatory Affairs Corporate Office, Nashville, Tennessee

Texas Oncology - Dallas Fort Worth, Dallas, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

US Oncology Research Investigational Products Center, Irving, Texas

Texas Oncology Northeast Texas, Tyler, Texas

Instituto Alexander Fleming, Capital Federal, Buenos Aires

Hospital Aleman, Ciudad Autonoma de Buenos Aires, Buenos Aires

Fundacion Cenit Para La Investigacion, Ciudad Autonoma de Buenos Aires, Buenos Aires

Hospital Italiano de La Plata, La Plata, Buenos Aires

Sociedad de Beneficencia Hospital Italiano, Cordoba, Córdoba

Fundacion Medica de Rio Negro y Neuquen, Cipolletti, Río Negro

Centro Oncologico Korben, Buenos Aires, Not set

Liverpool Hospital, Liverpool, New South Wales

Prince of Wales Hospital, Randwick, New South Wales

Wollongong Hospital, Wollongong, New South Wales

Toowoomba Hospital, Toowoomba, Queensland

Cabrini Hospital, Malvern, Victoria

St John of God Murdoch Hospital, Murdoch, Western Australia

Medizinische Universitaet Graz, Graz, Not set

Landeskrankenhaus Salzburg, Salzburg, Not set

Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, Not set

Grand Hopital de Charleroi - Site des Viviers, Charleroi, Not set

Universitair Ziekenhuis Antwerpen, Edegem, Not set

Universitair Ziekenhuis Gent, Gent, Not set

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven, Not set

Hospital das Clinicas da Ufmg, Belo Horizonte, Minas Gerais

Centro de Oncologia Mackenzie, Curitiba, Paraná

Associacao Hospitalar Moinhos de Vento, Porto Alegre, Rio Grande Do Sul

Instituto do Cancer Arnaldo Vieira de Carvalho, Sao Paulo, São Paulo

Beneficencia Portuguesa de Sao Paulo - Bp, Sao Paulo, São Paulo

Oncologia Rede D Or, Sao Paulo, São Paulo

Oncoclinicas Rio de Janeiro S A, Rio de Janeiro, Not set

Multiprofile Hospital for Active Treatment Central Onco Hospital OOD, Plovdiv, Not set

Complex Oncology Center Plovdiv EOOD, Plovdiv, Not set

Military Medical Academy Multiprofile Hospital for Active Treatment - Sofia, Sofia, Not set

Cross Cancer Institute, Edmonton, Alberta

The Ottawa Hospital Cancer Centre, Ottawa, Ontario

Princess Margaret Cancer Centre, Toronto, Ontario

Masarykuv onkologicky ustav, Brno, Not set

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Fakultni nemocnice Olomouc, Olomouc, Not set

Fakultni nemocnice Kralovske Vinohrady, Praha 10, Not set

Rigshospitalet, Kobenhavn O, Not set

Docrates Syopasairaala, Helsinki, Not set

Tampere University Hospital, Tampere, Not set

Institut de Cancerologie de l Ouest Rene Gauducheau, Angers Cedex 02, Not set

Centre Hospitalier Regional Universitaire de Besancon - Hopital Jean Minjoz, Besancon, Not set

Centre Oscar Lambret, Lille Cedex, Not set

Institut Paoli Calmettes, Marseille Cedex 09, Not set

Institut regional du Cancer Montpellier, Montpellier Cedex 5, Not set

Hopital Lyon sud, Pierre-Benite, Not set

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse cedex 9, Not set

Gustave Roussy, Villejuif, Not set

Sotiria General Hospital, Athens, Not set

Alexandra Hospital, Athens, Not set

Metropolitan General, Athens, Not set

University Hospital of Heraklion, Heraklion - Crete, Not set

European Interbalkan Medical Center, Thessaloniki, Not set

Semmelweis Egyetem, Budapest, Not set

Orszagos Onkologiai Intezet, Budapest, Not set

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz Nyiregyhazi Josa Andras Tagkorhaz, Nyiregyhaza, Not set

Jasz-Nagykun-Szolnok Varmegyei Hetenyi Geza Korhaz-Rendelointezet, Szolnok, Not set

Rambam Medical Center, Haifa, Not set

Hadassah Ein-Kerem Medical Center, Jerusalem, Not set

Rabin Medical Center, Petah Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Tel-Aviv Sourasky Medical Center, Tel Aviv, Not set

Istituto di Candiolo Fondazione del Piemonte per l Oncologia IRCCS, Candiolo TO, Not set

Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia, Foggia, Not set

Azienda Unita Locale Socio Sanitaria 3 Presidio Ospedaliero di Mirano, Mirano, Not set

Ospedale del Mare, Napoli, Not set

Azienda Ospedaliero Universitaria Pisana, Pisa, Not set

Azienda Ospedaliera Policlinico Umberto I, Roma, Not set

Aichi Cancer Center, Nagoya-shi, Aichi

National Cancer Center Hospital East, Kashiwa-shi, Chiba

Kindai University Hospital, Osakasayama-shi, Osaka

National Cancer Center Hospital, Chuo-ku, Tokyo

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Asan Medical Center, Seoul, Not set

Investigacion Onco Farmacéutica S de RL de CV, La Paz, Baja California Sur

Centro de Infusion e Investigacion Oncologia de Saltillo, Saltillo, Coahuila

Investigacion Biomedica para el Desarrollo de Farmacos, Ciudad de Mexico, Distrito Federal

Health Pharma Professional Research SA de CV, Mexico City, Distrito Federal

Christus Muguerza Clinica Vidriera, Monterrey, Nuevo León

Universitair Medisch Centrum Groningen, Groningen, Not set

Radboud Universitair Medisch Centrum, Nijmegen, Not set

Pratia Mcm Krakow, Krakow, Not set

Instytut Centrum Zdrowia Matki Polki, Lodz, Not set

Ars Medical Spzoo, Pila, Not set

Mazowiecki Szpital Wojewodzki im Sw Jana Pawla II w Siedlcach spzoo, Siedlce, Not set

Centrum Medyczne Pratia Poznan, Skorzewo, Not set

Unidade Local de Saude de Lisboa Ocidental, EPE - Hospital Sao Francisco Xavier, Lisboa, Not set

Hospital da Luz, SA, Lisboa, Not set

Unidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisboa, Not set

Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj Napoca, Not set

Centrul de Oncologie Sf Nectarie SRL, Craiova, Not set

Institutul Regional de Oncologie Iasi, Iasi, Not set

SC Oncomed SRL, Timisoara, Not set

Hospital Clinico Universitario Virgen de la Victoria, Malaga, Andalucía

Hospital Quironsalud Barcelona, Barcelona, Cataluña

Hospital Universitari Vall d Hebron, Barcelona, Cataluña

Hospital Clinico Universitario de Santiago, Santiago de Compostela, Galicia

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Kantonsspital Graubuenden, Chur, Not set

Hopitaux Universitaires de Geneve, Geneve, Not set

Christie Hospital, Manchester, Not set

Weston Park Hospital, Sheffield, Not set

Conditions: Solid Tumors

Learn More ›

JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation

NCT06386146

Recruiting

This study is to evaluate the efficacy and safety of JAB-30355 in adult participants with advanced solid tumors harboring TP53 Y220C mutation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/16/2025

Locations: Research Site, Denver, Colorado +12 locations

Conditions: Solid Tumors

Learn More ›

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

NCT05536141

Recruiting

The purpose of this study is to evaluate the safety and tolerability of: * casdatifan when taken alone in participants with advanced solid tumor malignancies and clear cell renal cell carcinoma (ccRCC) during the dose escalation stage; and * casdatifan monotherapy and casdatifan in combination with cabozantinib or zimberelimab in participants with ccRCC in the dose expansion stage

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/16/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +27 locations

University of Alabama at Birmingham, Birmingham, Alabama

University of California at San Diego, San Diego, California

UCLA, Santa Monica, California

University of Miami, Miami, Florida

Emory University, Atlanta, Georgia

University of Louisville Brown Cancer Center, Louisville, Kentucky

Oschner Health, New Orleans, Louisiana

Johns Hopkins Hospital, Baltimore, Maryland

Dana-Farber Cancer Institute, Boston, Massachusetts

Barbara Ann Karmanos Cancer Center, Detroit, Michigan

Henry Ford Health System, Detroit, Michigan

Nebraska Cancer Specialists - Oncology Hematology West PC, Omaha, Nebraska

Tisch Cancer Institute, Icahn Mount Sinai Hospital, New York, New York

University Hospitals Cleveland Clinical, Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Sarah Cannon, Nashville, Tennessee

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee

South Texas Accelerated Research Therapeutics, LLC, San Antonio, Texas

Medical Oncology Associates Summit Cancer Centers, Spokane, Washington

Chris O'Brien Lifehouse, Camperdown, Not set

Box Hill Hospital, Melbourne, Not set

Ashford Cancer Centre Research/ICON, Sydney, Not set

Macquarie University Hospital, Sydney, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Seoul National University Bundang Hospital, Seoul, Not set

Severance Hospital, Seoul, Not set

Conditions: Clear Cell Renal Cell Carcinoma, Solid Tumors

Learn More ›

A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)

NCT05471856

Recruiting

This study is open to adults with different types of advanced cancer. People can take part if previous treatment was not successful, or no treatment exists. The purpose of this study is to find the highest dose of a medicine called BI 1703880 that people with advanced cancer can tolerate when taken together with ezabenlimab. BI 1703880 and ezabenlimab are medicines that may help the immune system fight cancer. In this study, BI 1703880 is given to people for the first time. Participants get B... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2025

Locations: Valkyrie Clinical Trials, Los Angeles, California +12 locations

Conditions: Solid Tumors

Learn More ›

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

NCT06710132

Recruiting

The PROCEADE PanTumor study aims to investigate M9140 in multiple tumor types which express carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) and it is therefore designed as a matrix study. This study aims to assess the antitumor activity, tolerability, safety, and pharmacokinetics (PK) of M9140 as monotherapy or in combination treatments in adult participants with locally advanced/metastatic CEACAM5 expressing tumors. There will be 3 substudies under this Master Protocol that... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2025

Locations: NEXT Virginia, Fairfax, Virginia +3 locations

Conditions: Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

Learn More ›

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT03486873

Recruiting

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this extension study. This study will consist of three phases: 1) First Course Phase, 2) Survival Follow-up Phase or 3) Second Course Phase. Each participant will transition to this extension study in one of the following three phases, depending on the study phase they were in at the completion of the par... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/15/2025

Locations: Arizona Cancer Center at UMC North ( Site 0018), Tucson, Arizona +653 locations

Arizona Cancer Center at UMC North ( Site 0018), Tucson, Arizona

Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 0054), Bakersfield, California

California Cancer Associates for Research & Excellence ( Site 0016), Fresno, California

Providence Medical Foundation ( Site 0087), Fullerton, California

The Angeles Clinic and Research Institute ( Site 0005), Los Angeles, California

UCLA Hematology/Oncology - Westwood (Building 100) ( Site 0009), Los Angeles, California

University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0076), Orange, California

UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004), San Francisco, California

Providence Saint John's Health Center ( Site 0059), Santa Monica, California

Stanford Cancer Center ( Site 0086), Stanford, California

University of Colorado Cancer Center ( Site 0021), Aurora, Colorado

Yale Cancer Center ( Site 0014), New Haven, Connecticut

Georgetown University Medical Center ( Site 0023), Washington, District of Columbia

Holy Cross Hospital, Michael & Dianne Bienes Comp Cancer Ctr ( Site 0022), Fort Lauderdale, Florida

Baptist MD Anderson Cancer Center ( Site 0083), Jacksonville, Florida

Mount Sinai Medical Center Comprehensive Cancer Center ( Site 0031), Miami Beach, Florida

Moffitt Cancer Center ( Site 0011), Tampa, Florida

Emory School of Medicine ( Site 0013), Atlanta, Georgia

Augusta University ( Site 0077), Augusta, Georgia

Northwest Georgia Oncology Centers PC ( Site 0061), Marietta, Georgia

Kaiser Permanente Moanalua Medical Center ( Site 0063), Honolulu, Hawaii

The University of Chicago ( Site 0020), Chicago, Illinois

University of Iowa Hospital and Clinics ( Site 0026), Iowa City, Iowa

James Graham Brown Cancer Center ( Site 0058), Louisville, Kentucky

Mercy Health-Paducah Cancer Center ( Site 0084), Paducah, Kentucky

Women's Cancer Care ( Site 0088), Covington, Louisiana

MedStar Franklin Square Medical Center ( Site 0046), Baltimore, Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 0056), Baltimore, Maryland

Maryland Oncology Hematology (MOH) ( Site 8000), Columbia, Maryland

Massachusetts General Hospital ( Site 0041), Boston, Massachusetts

Dana-Farber Cancer Institute ( Site 0006), Boston, Massachusetts

Karmanos Cancer Institute ( Site 0047), Detroit, Michigan

Mayo Clinic in Rochester, Minnesota ( Site 0002), Rochester, Minnesota

Comprehensive Cancer Centers of Nevada ( Site 0043), Las Vegas, Nevada

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0038), Hackensack, New Jersey

Cancer Institute of New Jersey ( Site 0025), New Brunswick, New Jersey

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York, New York

Memorial Sloan Kettering Cancer Center ( Site 0012), New York, New York

White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains, New York

WakeMed Cancer Care - Waverly Hematology & Medical Oncology ( Site 0074), Cary, North Carolina

University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill, North Carolina

Levine Cancer Institute ( Site 0034), Charlotte, North Carolina

Duke Cancer Center ( Site 0028), Durham, North Carolina

Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065), Fargo, North Dakota

University Hospitals ( Site 0044), Cleveland, Ohio

Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0082), Tulsa, Oklahoma

Providence Portland Medical Center ( Site 0051), Portland, Oregon

St. Luke's University Health Network ( Site 0017), Bethlehem, Pennsylvania

University of Pennsylvania ( Site 0010), Philadelphia, Pennsylvania

Fox Chase Cancer Center ( Site 0042), Philadelphia, Pennsylvania

UPMC Hillman Cancer Center ( Site 0008), Pittsburgh, Pennsylvania

Sanford Cancer Center ( Site 0066), Sioux Falls, South Dakota

West Cancer Center and Research Institute ( Site 0055), Germantown, Tennessee

Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville, Tennessee

Vanderbilt Ingram Cancer Center ( Site 0015), Nashville, Tennessee

Texas Oncology - Central/South Texas ( Site 8001), Austin, Texas

Texas Oncology-Baylor Sammons Cancer Center ( Site 0062), Dallas, Texas

University of Texas MD Anderson Cancer Center ( Site 0007), Houston, Texas

South Texas Accelerated Research Therapeutics, LLC (START) ( Site 0001), San Antonio, Texas

University of Virginia Health System ( Site 0035), Charlottesville, Virginia

Bon Secours St. Francis Medical Center-Oncology Research ( Site 0075), Midlothian, Virginia

VCU Health Adult Outpatient Pavillion ( Site 0080), Richmond, Virginia

Blue Ridge Cancer Care ( Site 0067), Roanoke, Virginia

Fred Hutchinson Cancer Center ( Site 0024), Seattle, Washington

Centro de Oncología e Investigación de Buenos Aires ( Site 1357), Berazategui, Buenos Aires

Instituto Alexander Fleming ( Site 1364), Ciudad Autónoma de Buenos Aires, Buenos Aires

IDIM - Instituto de Investigaciones Metabólicas ( Site 1362), Ciudad de Buenos Aires, Buenos Aires

Instituto de Investigaciones Clínicas Mar del Plata ( Site 1363), Mar del Plata, Buenos Aires

Clinica Viedma ( Site 1353), Viedma, Rio Negro

Sanatorio Parque ( Site 1355), Rosario, Santa Fe

Instituto de Oncologia de Rosario ( Site 1350), Rosario, Santa Fe

Hospital Provincial del Centenario ( Site 1359), Rosario, Santa Fe

Hospital Aleman-Oncology ( Site 1351), Buenos Aires, Not set

Hospital Privado Universitario de Córdoba ( Site 1354), Cordoba, Not set

Fundación CORI para la Investigación y Prevención del Cáncer ( Site 1358), La Rioja, Not set

Instituto San Marcos ( Site 1366), San Juan, Not set

Centro Medico San Roque-Oncology ( Site 1352), Tucuman, Not set

Chris OBrien Lifehouse ( Site 3003), Camperdown, New South Wales

Royal Prince Alfred Hospital-A.W. Morrow Gastroenterology and Liver Centre ( Site 3016), Camperdown, New South Wales

Liverpool Hospital-Medical Oncology ( Site 3021), Liverpool, New South Wales

Macquarie University ( Site 3010), Macquarie University, New South Wales

Mater Hospital Sydney ( Site 3007), North Sydney, New South Wales

Orange Hospital-Clinical Trials Unit ( Site 3027), Orange, New South Wales

Port Macquarie - Mid North Coast Cancer Institute-Medical Oncology ( Site 3020), Port Macquarie, New South Wales

Royal North Shore Hospital-Medical Oncology Clinical Trials ( Site 3025), St Leonards, New South Wales

Calvary Mater Newcastle ( Site 3005), Waratah, New South Wales

Westmead Hospital ( Site 3000), Westmead, New South Wales

Melanoma Institute Australia ( Site 3001), Wollstonecraft, New South Wales

Mater Misericordiae Limited-Medical Oncology ( Site 3019), Brisbane, Queensland

Gallipoli Medical Research Ltd ( Site 3011), Brisbane, Queensland

Royal Brisbane and Women s Hospital ( Site 3009), Herston, Queensland

Tasman Oncology Research Pty Ltd ( Site 3012), Southport, Queensland

The Townsville Hospital ( Site 3017), Townsville, Queensland

Princess Alexandra Hospital ( Site 3002), Woolloongabba, Queensland

Royal Adelaide Hospital ( Site 3014), Adelaide, South Australia

The Queen Elizabeth Hospital ( Site 3026), Woodville, South Australia

Monash Health ( Site 3015), Clayton, Victoria

Austin Health-Austin Hospital ( Site 3004), Heidelberg, Victoria

Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 3008), Melbourne, Victoria

St Vincent's Hospital-Oncology Clinical Trials ( Site 3018), Melbourne, Victoria

Western Health-Sunshine & Footscray Hospitals ( Site 3023), St Albans, Victoria

Ballarat Oncology & Haematology Services ( Site 3022), Wendouree, Victoria

Sir Charles Gairdner Hospital ( Site 3006), Nedlands, Western Australia

St John of God Subiaco Hospital ( Site 3013), Subiaco, Western Australia

Kepler Universitätsklinikum ( Site 2955), Linz, Oberosterreich

Medical University of Graz ( Site 2952), Graz, Steiermark

Medizinische Universitaet Innsbruck ( Site 2951), Innsbruck, Tirol

Uniklinikum Salzburg ( Site 2956), Salzburg, Not set

Medizinische Universität Wien ( Site 2953), Wien, Not set

Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2954), Wien, Not set

AZ Sint-Maarten ( Site 2904), Mechelen, Antwerpen

Institut Jules Bordet ( Site 2903), Anderlecht, Bruxelles-Capitale, Region De

UZ Brussel ( Site 2900), Brussels, Bruxelles-Capitale, Region De

Cliniques universitaires Saint-Luc-Medical Oncology ( Site 2911), Brussels, Bruxelles-Capitale, Region De

Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 2905), Bruxelles, Bruxelles-Capitale, Region De

AZ Maria Middelares ( Site 2908), Gent, Oost-Vlaanderen

UZ Leuven ( Site 2901), Leuven, Vlaams-Brabant

UZ Leuven - Campus Gasthuisberg ( Site 2906), Leuven, Vlaams-Brabant

UZ Leuven Gasthuisberg, Gynaecologie-Verloskunde ( Site 2907), Leuven, Vlaams-Brabant

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godi, Namur, Not set

Hospital São Carlos-Oncocentro Ce ( Site 1029), Fortaleza, Ceara

CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA-Pesquisa Clínica ( Site 1024), Fortaleza, Ceara

Centro de Pesquisa Clínica do Instituto do Câncer do Ceará ( Site 1016), Fortaleza, Ceara

ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 1008), Ijui, Rio Grande Do Sul

Hospital de Clínicas de Passo Fundo ( Site 1025), Passo Fundo, Rio Grande Do Sul

Lacks - Oncologia E Hematologia ( Site 1026), Pelotas, Rio Grande Do Sul

Hospital de Clinicas de Porto Alegre ( Site 1000), Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS-Centro de Pesquisa em Oncologia ( Site 1006), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora da Conceição ( Site 1011), Porto Alegre, Rio Grande Do Sul

Clinica Viver ( Site 1021), Santa Maria, Rio Grande Do Sul

CEPON ( Site 1012), Florianópolis, Santa Catarina

Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1010), Barretos, Sao Paulo

Hospital Amaral Carvalho ( Site 1023), Jaú, Sao Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site, São José do Rio Preto, Sao Paulo

Clínica de Pesquisa e Centro de Estudos em Ginecologia Oncológica e Mamária LTDA ( Site 1017), São Paulo, Sao Paulo

Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 1020), Rio de Janeiro, Not set

Instituto de de Educação, pesquisa e Gestão em Saúde ( Site 1014), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 1001), Sao Paulo, Not set

BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 1030), Sao Paulo, Not set

A. C. Camargo Cancer Center ( Site 1002), Sao Paulo, Not set

Arthur J.E. Child Comprehensive Cancer Centre ( Site 2815), Calgary, Alberta

Cross Cancer Institute ( Site 2804), Edmonton, Alberta

CancerCare Manitoba ( Site 2814), Winnipeg, Manitoba

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 2801), Hamilton, Ontario

Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 2808), Kingston, Ontario

London Regional Cancer Program - LHSC ( Site 2806), London, Ontario

The Ottawa Hospital - General Campus ( Site 2813), Ottawa, Ontario

Sunnybrook Research Institute ( Site 2802), Toronto, Ontario

Mount Sinai Hospital ( Site 2811), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 2803), Toronto, Ontario

Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre-Oncology ( Site 2809), Greenfield Park, Quebec

Centre Intégré de Santé et de Services Sociaux (CISSS) de La-Centre intégré de cancérologie de Lava, Laval, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 2807), Montreal, Quebec

Jewish General Hospital ( Site 2800), Montreal, Quebec

McGill University Health Centre ( Site 2818), Montreal, Quebec

Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer, Sherbrooke, Quebec

Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec (, Trois-Rivières, Quebec

Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 2, Quebec, Not set

James Lind Centro de Investigacion del Cancer ( Site 2757), Temuco, Araucania

Orlandi Oncologia-Oncology ( Site 2752), Santiago, Region M. De Santiago

Fundacion Arturo Lopez Perez FALP ( Site 2750), Santiago, Region M. De Santiago

Oncovida ( Site 2759), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 2751), Santiago, Region M. De Santiago

Instituto Nacional del Cancer-CR Investigación ( Site 2753), Santiago, Region M. De Santiago

Bradfordhill-Clinical Area ( Site 2756), Santiago, Region M. De Santiago

ONCOCENTRO APYS-ACEREY ( Site 2758), Viña del Mar, Valparaiso

Centro de Investigaciones ( Site 2755), Viña del Mar, Valparaiso

Anhui Provincial Hospital-Cancer Chemotherapy Department ( Site 3480), Hefei, Anhui

Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 3487), Hefei, Anhui

Beijing Cancer Hospital ( Site 3451), Beijing, Beijing

The Fifth Medical Center Of The Chinese PLA General Hospital (South) ( Site 3465), Beijing, Beijing

Beijing Cancer Hospital ( Site 3499), Beijing, Beijing

Beijing Cancer Hospital ( Site 3500), Beijing, Beijing

Beijing Cancer hospital-Thoracic Cancer Department A ( Site 3454), Beijing, Beijing

Chinese Academy of medical science, Peking Union Medical College Hospital(Dongdan) ( Site 3466), Beijing, Beijing

Army Medical Center of People's Liberation Army-Oncology Department ( Site 3477), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 3461), Fuzhou, Fujian

Southern medical university Nangfang Hospital ( Site 3490), Guanghzou, Guangdong

The Sixth Affiliated Hospital of Sun Yat-sen University ( Site 3491), Guangzhou, Guangdong

SUN YAT-SEN UNIVERSITY CANCER CENTRE-Internal Medicine ( Site 3452), Guangzhou, Guangdong

Sun Yat-sen University Cancer Center-melanoma ( Site 3482), Guangzhou, Guangdong

Guangdong Provincial People's Hospital-Cancer Center ( Site 3462), Guangzhou, Guangdong

The First Affiliated Hospital, Sun Yat-sen University-pneumology department ( Site 3459), Guangzhou, Guangdong

The First Affiliated Hospital of Guangzhou Medical University-thoracic surgery department ( Site 346, Guangzhou, Guangdong

The Affiliated Cancer Hospital of Guizhou Medical University ( Site 3498), Guiyang, Guizhou

Harbin Medical University Cancer Hospital-Harbin Medical University Cancer Hospital ( Site 3475), Harbin, Heilongjiang

Henan Cancer Hospital ( Site 3488), Zhengzhou, Henan

Tongji Hospital Tongji Medical,Science & Technology-oncology ( Site 3476), Wuhan, Hubei

Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 3492), Wuhan, Hubei

Xiangya Hospital Central South University-Gynecology ( Site 3497), Changsha, Hunan

Xiangya Hospital Central South University-Respiratory ( Site 3479), Changsha, Hunan

Hunan Cancer Hospital ( Site 3485), Changsha, Hunan

Hunan Cancer Hospital ( Site 3501), Changsha, Hunan

Jiangsu Cancer Hospital-Medical Oncotherapy ( Site 3469), Nanjing, Jiangsu

Yancheng First People s Hospital ( Site 3504), Yancheng, Jiangsu

Northern Jiangsu People's Hospital-General Surgery Department ( Site 3474), Yangzhou, Jiangsu

The First Hospital of Jilin University-Oncology ( Site 3464), Changchun, Jilin

Jilin Province Tumor Hospital ( Site 3484), Changchun, Jilin

Tangdu Hospital of Fourth Military Medical University of Chi-department of radiotherapy ( Site 3455), Xi'an, Shaanxi

Fudan University Shanghai Cancer Center ( Site 3467), Shanghai, Shanghai

Obstetrics & Gynecology Hospital of Fudan University ( Site 3494), Shanghai, Shanghai

Shanghai Pulmonary Hospital ( Site 3470), Shanghai, Shanghai

The First Affiliated Hospital of Xi an Jiaotong University ( Site 3489), XiAn, Shanxi

West China Hospital Sichuan University-respiratory ( Site 3473), Cheng Du, Sichuan

Tianjin Medical University Cancer Institute and Hospital ( Site 3456), Tianjin, Tianjin

Xinjiang Medical University Cancer Hospital - Urumqi-galactophore department ( Site 3486), Urumqi, Xinjiang

The Affiliated Cancer Hospital of Xinjiang Medical University ( Site 3502), Urumqi, Xinjiang

Women s Hospital School of Medicine Zhejiang University ( Site 3493), Hangzhou, Zhejiang

Hangzhou Cancer Hospital-Medical Oncology ( Site 3468), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 3495), Hangzhou, Zhejiang

Sir Run Run Shaw Hospital ( Site 3505), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 3481), Hangzhou, Zhejiang

Instituto de Cancerología-Oncology ( Site 2702), Medellín, Antioquia

Fundacion Colombiana de Cancerología Clinica Vida ( Site 2707), Medellín, Antioquia

Clinica de la Costa S.A.S. ( Site 2705), Barranquilla, Atlantico

Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2704), Valledupar, Cesar

Oncomédica S.A.S ( Site 2703), Montería, Cordoba

Instituto Nacional De Cancerologia-Oncología Clínica ( Site 2706), Bogota, Cundinamarca

Administradora Country S.A. ( Site 2701), Bogota, Distrito Capital De Bogota

Fundación Valle del Lili ( Site 2700), Cali, Valle Del Cauca

Clínica Imbanaco S.A.S ( Site 2708), Cali, Valle Del Cauca

CIMCA ( Site 3900), San Jose, Not set

Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0703), Brno, Brno-mesto

Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0704), Olomouc, Olomoucky Kraj

Fakultni Thomayerova nemocnice-Onkologicka klinika 1. LF UK ( Site 0702), Prague, Praha 4

Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0705), Praha, Praha 5

Fakultni nemocnice Olomouc ( Site 0701), Olomouc, Not set

Fakultni nemocnice v Motole ( Site 0700), Praha 5, Not set

Odense Universitetshospital ( Site 0650), Odense, Syddanmark

Vejle Sygehus ( Site 0653), Vejle, Syddanmark

Tartu University Hospital-Radiotherapy and oncology ( Site 3800), Tartu, Tartumaa

Tampere University Hospital [Tampere Finland] ( Site 0600), Tampere, Pirkanmaa

Turku University Hospital ( Site 0601), Turku, Varsinais-Suomi

Centre Hospitalier Universitaire de Nice - Hôpital l'Archet-Dermatology Department ( Site 2539), Nice, Alpes-Maritimes

Nouvel Hôpital Civil (NHC) ( Site 2529), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque ( Site 2534), Pessac, Aquitaine

Centre Hopitalar Leon-Berard ( Site 2519), Lyon, Auvergne

Hopital Nord ( Site 2516), Marseille, Bouches-du-Rhone

Hôpital Privé Clairval ( Site 2549), Marseille, Bouches-du-Rhone

CHU La Timone ( Site 2508), Marseille, Bouches-du-Rhone

Centre Georges François Leclerc-Centre de recherche clinique ( Site 2536), Dijon, Cote-d Or

CHU Jean Minjoz ( Site 2520), Besancon, Doubs

CHU-Jean Minjoz ( Site 2550), Besançon, Doubs

CHRU Brest - Hopital Cavale Blanche ( Site 2504), Brest, Finistere

Institut Bergonie ( Site 2502), Bordeaux, Gironde

CHU Toulouse - Hopital Rangueil ( Site 2518), Toulouse, Haute-Garonne

CHU de Toulouse - Hopital Larrey-service de pneumologie ( Site 2526), Toulouse, Haute-Garonne

Ambroise Pare Hopital ( Site 2503), Boulogne, Hauts-de-Seine

Hôpital Foch ( Site 2543), Suresnes, Hauts-de-Seine

Hôpital Beaujon ( Site 2524), Clichy, Ile-de-France

Groupe hospitalier Paris saint Joseph-Service de Pneumologie-Allergologie -Oncologie Thoracique ( Si, Paris, Ile-de-France

Institut Gustave Roussy ( Site 2513), Villejuif, Ile-de-France

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 2525), Rennes, Ille-et-Vilaine

Hopital Trousseau ( Site 2512), Chambray-les-Tours, Indre-et-Loire

C.H.U. de Tours - Hopital Bretonneau ( Site 2515), Tours, Indre-et-Loire

Institut de Cancérologie de l'Ouest-Oncologie Médicale ( Site 2522), Saint Herblain, Loire-Atlantique

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes-lung oncology ( Site 2546), Saint-Herblain, Loire-Atlantique

Institut de Cancérologie de Lorraine Alexis Vautrin ( Site 2532), Vandoeuvre-lès-Nancy, Lorraine

Centre Oscar Lambret ( Site 2551), Lille, Nord-Pas-de-Calais

CHRU Lille Hospital Claude Huriez ( Site 2506), Lille, Nord

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 2542), Clermont-Ferrand, Puy-de-Dome

CH Lyon Sud Hospices Civils de Lyon ( Site 2521), Pierre Benite, Rhone-Alpes

C.H.U. Pontchaillou ( Site 2511), Pierre Benite, Rhone

Centre Hospitalier du Mans-Pneumologie ( Site 2527), Le Mans, Sarthe

Centre Henri Becquerel ( Site 2547), Rouen, Seine-Maritime

Hôpital Avicenne-Dermatologie ( Site 2538), Bobigny, Seine-Saint-Denis

Clinique de L'Europe ( Site 2548), Amiens, Somme

Centre Hopitalier Intercommunal Creteil ( Site 2514), Creteil, Val-de-Marne

Hôpital Universitaire Paul Brousse ( Site 2541), Villejuif, Val-de-Marne

Centre Hospitalier Universitaire de Poitiers-Dermatologie ( Site 2544), Poitiers, Vienne

Hopital Cochin ( Site 2509), Paris, Not set

Hopital Saint Louis ( Site 2510), Paris, Not set

CHU Hopital Saint Antoine ( Site 2517), Paris, Not set

Groupe Hospitalier Diaconesses Croix Saint Simon ( Site 2545), Paris, Not set

Hôpital Tenon ( Site 2530), Paris, Not set

Universitaetsklinikum Tuebingen ( Site 2405), Tuebingen, Baden-Wurttemberg

Universitätsklinikum Erlangen ( Site 2408), Erlangen, Bayern

Universitaetsklinik Muenchen ( Site 2406), Muenchen, Bayern

Krankenhaus Nordwest ( Site 2409), Frankfurt, Hessen

Elbe Klinikum Buxtehude ( Site 2400), Buxtehude, Niedersachsen

Medizinische Hochschule Hannover ( Site 2402), Hannover, Niedersachsen

Universitaetsklinikum Essen ( Site 2404), Essen, Nordrhein-Westfalen

Universitaetsklinikum des Saarlandes-Klinik für Innere Medizin V-Pneumologie, Allergologie, Beatmun, Homburg, Saarland

Universitatsklinikum Carl Gustav Carus ( Site 2407), Dresden, Sachsen

LungenClinic Grosshansdorf GmbH ( Site 2412), Grosshansdorf, Schleswig-Holstein

SRH Wald-Klinikum Gera GmbH ( Site 2403), Gera, Thuringen

Helios Klinikum Emil von Behring Berlin-Zehlendorf-Lungenklinik Heckeshorn ( Site 2418), Berlin, Not set

Facharztzentrum Eppendorf ( Site 2415), Hamburg, Not set

General Hospital of Athens "Laiko"-Hematology Department ( Site 1851), Athens, Attiki

Sotiria Regional Chest Diseases Hospital of Athens ( Site 1850), Athens, Attiki

MEDI-K ( Site 3403), Guatemala, Not set

Oncomedica ( Site 3401), Guatemala, Not set

Grupo Medico Angeles ( Site 3402), Guatemala, Not set

Queen Mary Hospital ( Site 1902), Hksar, Not set

Queen Mary Hospital-Department of Medicine (Respiratory) ( Site 1900), Hksar, Not set

Princess Margaret Hospital ( Site 1903), Hong Kong, Not set

Békés Megyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 1405), Gyula, Bekes

Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Oktatókórház ( Site 1409), Miskolc, Borsod-Abauj-Zemplen

Fejér Megyei Szent György Egyetemi Oktató Kórház-l.Pulmonologia ( Site 1407), Székesfehérvár, Fejer

Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 1401), Szolnok, Jasz-Nagykun-Szolnok

Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 1411), Budapest, Pest

Markusovszky Egyetemi Oktatokorhaz-Onkológiai Osztály ( Site 1410), Szombathely, Vas

Farkasgyepui Tudogyogyintezet-Pulmonologia ( Site 1414), Farkasgyepu, Veszprem

Semmelweis University-Belgyógyászati és Hematológiai Klinika ( Site 1406), Budapest, Not set

Orszagos Koranyi Pulmonologiai Intezet ( Site 1403), Budapest, Not set

Uzsoki Utcai Kórház-Onkoradiológiai Osztály ( Site 1413), Budapest, Not set

Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Haematologia) ( Site 1415), Debrecen, Not set

Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 1412), Debrecen, Not set

Somogy Megyei Kaposi Mor Oktato Korhaz ( Site 1402), Kaposvar, Not set

Zala Megyei Szent Rafael Korhaz ( Site 1400), Zalaegerszeg, Not set

Mater Misercordiae University Hospital ( Site 1800), Dublin, Leinster

Tallaght University Hospital ( Site 1803), Dublin, Not set

St. James s Hospital ( Site 1801), Dublin, Not set

Rambam Health Care Campus-Oncology Division ( Site 2053), Haifa, Not set

Bnai Zion Medical Center ( Site 2060), Haifa, Not set

Hadassah Ein Kerem Medical Center ( Site 2051), Jerusalem, Not set

Rabin Medical Center ( Site 2059), Petah-Tikva, Not set

Chaim Sheba Medical Center. ( Site 2052), Ramat Gan, Not set

Chaim Sheba Medical Center ( Site 2055), Ramat Gan, Not set

Sheba Medical Center ( Site 2062), Ramat Gan, Not set

Sheba Medical Center ( Site 2065), Ramat Gan, Not set

ZIV Medical Center-Hematology Institute ( Site 2061), Safed, Not set

Sourasky Medical Center ( Site 2054), Tel Aviv, Not set

Shamir Medical Center Assaf Harofeh ( Site 2058), Zerifin, Not set

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola ( Site 1978), Bologna, Emilia-Romagna

Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 1963), Roma, Lazio

Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1975), Roma, Lazio

Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1977), Milan, Lombardia

Azienda Ospedaliera San Gerardo ( Site 1980), Monza, Lombardia

Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1968), Rozzano, Milano

IRCCS CRO Aviano, Hematology/Oncology ( Site 1957), Aviano, Pordenone

Ospedale Cannizzaro ( Site 1981), Catania, Sicilia

Istituto di Candiolo - IRCCS ( Site 1960), Candiolo, Torino

Ospedale San Luigi Gonzaga ( Site 1956), Orbassano, Torino

AO Santa Maria della Misericordia-Oncology Department ( Site 1971), Perugia, Umbria

Istituto Oncologico Veneto IRCCS ( Site 1976), Padova, Veneto

Humanitas Gavazzeni ( Site 1954), Bergamo, Not set

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII-UOC Oncologia ( Site 1967), Bergamo, Not set

Azienda Ospedaliera Spedali Civili di Brescia-Oncology ( Site 1972), Brescia, Not set

IRCCS A.O.U. San Martino - IST ( Site 1961), Genova, Not set

Ospedale San Raffaele. ( Site 1979), Milano, Not set

Istituto Europeo di Oncologia ( Site 1952), Milano, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1955), Napoli, Not set

Azienda Ospedaliero Universitaria di Parma-UO Oncologia Medica ( Site 1964), Parma, Not set

Fondazione IRCCS Policlinico San Matteo ( Site 1982), Pavia, Not set

Azienda Ospedaliera San Camillo Forlanini ( Site 1958), Roma, Not set

Policlinico Universitario Agostino Gemelli ( Site 1965), Roma, Not set

ospedale le scotte-U.O.C. Immunoterapia Oncologica ( Site 1969), Siena, Not set

Azienda Ospedaliera Santa Maria ( Site 1962), Terni, Not set

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino ( Site 1974), Torino, Not set

Nagoya University Hospital ( Site 3151), Nagoya-Shi, Aichi

National Hospital Organization Nagoya Medical Center ( Site 3109), Nagoya, Aichi

Aichi Cancer Center Hospital ( Site 3101), Nagoya, Aichi

National Cancer Center Hospital East ( Site 3121), Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center ( Site 3116), Matsuyama, Ehime

Ehime University Hospital ( Site 3158), Toon,, Ehime

Kurume University Hospital ( Site 3105), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 3160), Sapporo, Hokkaido

Sapporo Kosei General Hospital ( Site 3172), Sapporo, Hokkaido

Sapporo Medical University Hospital ( Site 3113), Sapporo, Hokkaido

Hokkaido University Hospital ( Site 3165), Sapporo, Hokkaido

Hyogo Cancer Center ( Site 3131), Akashi, Hyogo

National Hospital Organization Himeji Medical Center ( Site 3111), Himeji, Hyogo

Kobe City Medical Center General Hospital ( Site 3144), Kobe, Hyogo

Hyogo Medical University Hospital ( Site 3100), Nishinomiya, Hyogo

Ibaraki Prefectural Central Hospital ( Site 3180), Kasama, Ibaraki

University of Tsukuba Hospital ( Site 3176), Tsukuba, Ibaraki

Kanazawa University Hospital ( Site 3140), Kanazawa, Ishikawa

Iwate Medical University Hospital ( Site 3157), Shiwa-gun, Iwate

Kagawa University Hospital ( Site 3171), Kita, Kagawa

Nippon Medical School Musashi Kosugi Hospital ( Site 3178), Kawasaki, Kanagawa

Kitasato University Hospital ( Site 3142), Sagamihara, Kanagawa

Yokohama City University Hospital ( Site 3163), Yokohama, Kanagawa

Kanagawa Cancer Center ( Site 3137), Yokohama, Kanagawa

Yokosuka Kyosai Hospital ( Site 3150), Yokosuka, Kanagawa

Miyagi Cancer Center ( Site 3122), Natori, Miyagi

Tohoku University Hospital ( Site 3175), Sendai-shi, Miyagi

Sendai Kousei Hospital ( Site 3115), Sendai, Miyagi

Nara Medical University Hospital ( Site 3110), Kashihara, Nara

Niigata Cancer Center Hospital ( Site 3173), Niigata-shi, Niigata

Kurashiki Central Hospital ( Site 3132), Kurashiki, Okayama

University of the Ryukyus Hospital ( Site 3155), Ginowan, Okinawa

Osaka International Cancer Institute ( Site 3129), Chuo-ku, Osaka

Osaka Habikino Medical Center ( Site 3138), Habikino, Osaka

Kansai Medical University Hospital ( Site 3126), Hirakata, Osaka

Kindai University Hospital ( Site 3102), Osakasayama, Osaka

Kindai University Hospital ( Site 3135), Osakasayama, Osaka

Osaka Rosai Hospital ( Site 3148), Sakai, Osaka

Kindai University Hospital ( Site 3166), Sayama, Osaka

The University of Osaka Hospital ( Site 3168), Suita, Osaka

Osaka Medical and Pharmaceutical University Hospital ( Site 3167), Takatsuki, Osaka

Saitama Medical University International Medical Center ( Site 3118), Hidaka, Saitama

Saitama Prefectural Cancer Center ( Site 3112), Kitaadachi-gun, Saitama

Dokkyo Medical University Saitama Medical Center ( Site 3152), Koshigaya, Saitama

National Defense Medical College Hospital ( Site 3177), Tokorozawa, Saitama

Shizuoka Cancer Center ( Site 3128), Nagaizumi, Shizuoka

Jichi Medical University Hospital ( Site 3141), Shimotsuke, Tochigi

Institute of Science Tokyo Hospital ( Site 3149), Bunkyō, Tokyo

Cancer Institute Hospital of JFCR ( Site 3146), Koto, Tokyo

Cancer Institute Hospital of JFCR ( Site 3164), Koto, Tokyo

Toranomon Hospital ( Site 3134), Minato-ku, Tokyo

Toranomon Hospital ( Site 3153), Minato-ku, Tokyo

Kyorin University Hospital ( Site 3147), Mitaka-shi, Tokyo

Kyorin University Hospital ( Site 3103), Mitaka, Tokyo

Tokyo Medical University Hospital ( Site 3170), Shinjuku-ku, Tokyo

National Hospital Organization Yamaguchi Ube Medical Center ( Site 3123), Ube, Yamaguchi

Yamaguchi University Hospital ( Site 3114), Ube, Yamaguchi

Chiba Cancer Center ( Site 3117), Chiba, Not set

National Hospital Organization Kyushu Medical Center ( Site 3136), Fukuoka, Not set

National Hospital Organization Kyushu Cancer Center ( Site 3169), Fukuoka, Not set

Kyushu University Hospital ( Site 3143), Fukuoka, Not set

Kyushu University Hospital ( Site 3185), Fukuoka, Not set

Gifu University Hospital ( Site 3161), Gifu, Not set

Hiroshima City Hiroshima Citizens Hospital ( Site 3119), Hiroshima, Not set

Hiroshima University Hospital ( Site 3154), Hiroshima, Not set

Kochi Health Sciences Center ( Site 3145), Kochi, Not set

Kumamoto University Hospital ( Site 3179), Kumamoto, Not set

Niigata University Medical & Dental Hospital ( Site 3174), Niigata, Not set

Okayama University Hospital ( Site 3107), Okayama, Not set

Osaka City General Hospital ( Site 3125), Osaka, Not set

National Hospital Organization Osaka National Hospital ( Site 3162), Osaka, Not set

Osaka General Medical Center ( Site 3184), Osaka, Not set

National Cancer Center Hospital ( Site 3130), Tokyo, Not set

St.Luke's International Hospital ( Site 3120), Tokyo, Not set

The Jikei University Hospital ( Site 3156), Tokyo, Not set

Nippon Medical School Hospital ( Site 3139), Tokyo, Not set

Tokyo Metropolitan Komagome Hospital ( Site 3133), Tokyo, Not set

Cancer Institute Hospital of JFCR ( Site 3108), Tokyo, Not set

Keio University Hospital ( Site 3127), Tokyo, Not set

Teikyo University Hospital ( Site 3104), Tokyo, Not set

Wakayama Medical University Hospital ( Site 3124), Wakayama, Not set

Chungbuk National University Hospital ( Site 0961), Cheongju-si, Chungbuk

Gachon University Gil Medical Center ( Site 0967), Inceon, Incheon

Chonnam National University Hwasun Hospital-Hemato-Oncology ( Site 0959), Hwasun, Jeonranamdo

National Cancer Center ( Site 0955), Goyang-si, Kyonggi-do

CHA Bundang Medical Center CHA University ( Site 0957), Seongnam si, Kyonggi-do

Seoul National University Bundang Hospital ( Site 0951), Seongnam-si, Kyonggi-do

Gangnam Severance Hospital, Yonsei University Health System ( Site 0966), Gangnam-gu, Seoul

Asan Medical Center ( Site 0952), Songpagu, Seoul

Keimyung University Dongsan Hospital CRC room 1 ( Site 0960), Daegu, Taegu-Kwangyokshi

Kyungpook National University Chilgok Hospital ( Site 0964), Deagu, Taegu-Kwangyokshi

Chungnam national university hospital-Department of Internal Medicine ( Site 0958), Daejeon, Taejon-Kwangyokshi

Korea University Anam Hospital ( Site 0956), Seoul, Not set

Seoul National University Hospital ( Site 0953), Seoul, Not set

Severance Hospital ( Site 0954), Seoul, Not set

Severance Hospital, Yonsei University Health System ( Site 0962), Seoul, Not set

Samsung Medical Center ( Site 0950), Seoul, Not set

Korea University Guro Hospital ( Site 0963), Seoul, Not set

Liepjas reionl slimnca ( Site 3851), Liepaja, Not set

RIGA EAST UNIVERSITY HOSPITAL ,Oncology Centre of Latvia-Out-patient and Day patient facility of Ch, Riga, Not set

Klaipeda University Hospital-Oncology chemotherapy ( Site 3302), Klaipeda, Klaipedos Miestas

National Cancer Institute-Chemotherapy departament with day care unit ( Site 3301), Vilnius, Vilniaus Miestas

Vilniaus Universiteto Ligonine Santaros Klinikos ( Site 3300), Vilnius, Not set

Hospital Tengku Ampuan Afzan ( Site 0627), Kuantan, Pahang

Gleneagles Penang ( Site 0625), Georgetown, Pulau Pinang

Pantai Hospital Kuala Lumpur ( Site 0628), Kuala Lumpur, Not set

University Malaya Medical Centre ( Site 0626), Kuala Lumpur, Not set

Investigación Oncofarmacéutica-Investigación clínica ( Site 1114), La Paz, Baja California Sur

INSTITUTO NACIONAL DE CANCEROLOGIA ( Site 1102), Ciudad de Mexico, Distrito Federal

Avix Investigación Clinica, S.C.-Oncology ( Site 1104), Monterrey, Nuevo Leon

Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 1113), Monterrey, Nuevo Leon

Oaxaca Site Management Organization ( Site 1106), Oaxaca de Juarez, Oaxaca

Medical Care and Research SA de CV ( Site 1103), Merida, Yucatan

Oncare Viaducto Napoles ( Site 1107), Mexico City, Not set

Radboud University Medical Center ( Site 1554), Nijmegen, Gelderland

Antoni van Leeuwenhoek Ziekenhuis ( Site 1551), Amsterdam, Noord-Holland

Amsterdam UMC, locatie VUmc ( Site 1555), Amsterdam, Noord-Holland

Erasmus MC ( Site 1553), Rotterdam, Zuid-Holland

Universitair Medisch Centrum Groningen ( Site 1550), Groningen, Not set

Canterbury Regional Cancer & Blood Service ( Site 1500), Christchurch, Canterbury

Waikato Hospital ( Site 1502), Hamilton, Waikato

Auckland City Hospital ( Site 1503), Auckland, Not set

Capital & Coast District Health Board - Wellington Hospital ( Site 1501), Wellington, Not set

Helse Bergen Haukeland universitetssykehus ( Site 1451), Bergen, Vestfold

Oslo Universitetssykehus Radiumhospitalet ( Site 1450), Oslo, Not set

Oslo universitetssykehus, Radiumhospitalet ( Site 1452), Oslo, Not set

IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0678), Lima, Not set

INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0681), Lima, Not set

Hospital Cayetano Heredia-Oncology ( Site 0675), Lima, Not set

Makati Medical Center ( Site 1702), Makati, National Capital Region

Lung Center of the Philippines ( Site 1705), Quezon City, National Capital Region

St. Luke s Medical Center ( Site 1700), Quezon City, National Capital Region

Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 1612), Bydgoszcz, Kujawsko-pomorskie

Powiatowe Centrum Zdrowia w Brzezinach Sp. z o. o. Oddział Dziennej Chemioterapii ( Site 1611), Brzeziny, Lodzkie

Instytut Centrum Zdrowia Matki Polki-Klinika Onkologii ( Site 1609), Łódź, Lodzkie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 1608), Krakow, Malopolskie

Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie-Oncology Department ( Site 1618), Kraków, Malopolskie

Luxmed Onkologia sp. z o. o. ( Site 1621), Warszawa, Mazowieckie

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie (, Warszawa, Mazowieckie

Wojskowy Instytut Medyczny-Klinika Onkologii ( Site 1606), Warszawa, Mazowieckie

Opolskie Centrum Onkologii w Opolu im. prof. Tadeusza Kosza-Klinika Onkologii z Odcinkiem Dziennym, Opole, Opolskie

Bialostockie Centrum Onkologii ( Site 1610), Bialystok, Podlaskie

Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1620), Gliwice, Slaskie

Przychodnia Lekarska KOMED ( Site 1603), Konin, Wielkopolskie

Med-Polonia Sp. z o. o. ( Site 1605), Poznan, Wielkopolskie

Szpital Kliniczny im. Przemienienia Panskiego Uniwersytetu Medycznego im. K. Marcinkowskiego w Pozna, Poznan, Wielkopolskie

Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 1619), Poznan, Wielkopolskie

Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1614), Koszalin, Zachodniopomorskie

Champalimaud Foundation ( Site 1751), Lisbon, Lisboa

Unidade Local de Saude de Santa Maria - Hospital Pulido Valente ( Site 1750), Lisboa, Not set

Instituto Português de Oncologia do Porto Francisco Gentil, EPE-Oncologia Médica ( Site 1753), Porto, Not set

Centro Hospitalar de Sao Joao - Hospital de Sao Joao ( Site 1752), Porto, Not set

Ad-Vance Medical Research-Research ( Site 1151), Ponce, Not set

FDI Clinical Research ( Site 1152), San Juan, Not set

UPR Comprehensive Cancer Center ( Site 1150), San Juan, Not set

Spitalul Județean Sfântul Ioan cel Nou Suceava-Oncology ( Site 3550), Suceava, Not set

Altai Regional Clinical Oncology Center ( Site 1229), Barnaul, Altayskiy Kray

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1204), Ufa, Baskortostan, Respublika

Bashkir State Medical University ( Site 1221), Ufa, Baskortostan, Respublika

Belgorod Oncology Dispensary ( Site 1213), Belgorod, Belgorodskaya Oblast

Regional Budgetary Healthcare Institution 'Ivanovo Regional Oncology Dispensary'-Urology ( Site 1219, Ivanovo, Ivanovskaya Oblast

GBUZ LOKB ( Site 1218), Saint-Petersburg, Leningradskaya Oblast

GBUZ LOKB-Oncology department #1 ( Site 1222), Saint-Petersburg, Leningradskaya Oblast

Ogarev Mordovia State University ( Site 1206), Saransk, Mordoviya, Respublika

The National Medico-Surgical Center N.I. Pirogov ( Site 1225), Moscow, Moskva

N.N. Blokhin NMRCO ( Site 1209), Moscow, Moskva

Russian Oncological Research Center n.a. N.N.Blokhin of MoH ( Site 1201), Moscow, Moskva

FSBI-FRCC of Special Types Med. Care and Technologies FMBA of Russia ( Site 1234), Moscow, Moskva

Russian Scientific Center of Roentgenoradiology ( Site 1215), Moscow, Moskva

P. A. Hertsen Moscow Oncology Research Center ( Site 1214), Moscow, Moskva

FSAI Treatment and Rehabilitation Centre of the MoH and SD of RF ( Site 1208), Moscow, Moskva

Russian Scientific Research Institute of Hematology and Blood Transfusion-Hematology ( Site 1224), Saint Petersburg, Sankt-Peterburg

First Pavlov State Medical University of Saint Petersburg ( Site 1232), Saint Petersburg, Sankt-Peterburg

Almazov National Medical Research Centre ( Site 1233), Saint Petersburg, Sankt-Peterburg

N.N.Petrov Research Institute of Oncology-Department of Preclinical and Clinical Research ( Site 121, Saint Petersburg, Sankt-Peterburg

Clinical Research Center of specialized types medical care-Oncology ( Site 1205), Saint-Petersburg, Sankt-Peterburg

EuroCityClinic ( Site 1230), St Petersburg, Sankt-Peterburg

St. Petersburg Clinical Hospital of Russian Academy Of Sciences ( Site 1235), St. Petersburg, Sankt-Peterburg

National Medical Research Center of Oncology N.A. N.N. Petrov ( Site 1210), St. Petersburg, Sankt-Peterburg

GBUZ SK Pyatigorsk Interdistrict Oncology dispensary ( Site 1223), Pyatigorsk, Stavropol Skiy Kray

Republican Clinical Oncology Dispensary ( Site 1228), Kazan, Tatarstan, Respublika

Republican Clinical Oncology Dispensary of Tatarstan MoH named after professor M.Z. Sigal ( Site 120, Kazan, Tatarstan, Respublika

Tomsk Scientific Research Institute of Oncology ( Site 1227), Tomsk, Tomskaya Oblast

SAIH of the Tyumen region, Multidisciplinary Clinical Medical Center "Medical town" ( Site 1220), Tyumen, Tyumenskaya Oblast

Udmurtian Republican Clinical Oncology Center ( Site 1212), Izhevsk, Udmurtskaya Respublika

National Cancer Centre Singapore ( Site 2200), SIngapore, Central Singapore

National University Hospital-Haematology -Oncology Research Group ( Site 2201), Singapore, South West

WCR Office ( Site 2002), Johannesburg, Gauteng

Wilgers Oncology Centre ( Site 2006), Pretoria, Gauteng

LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 2005), Pretoria, Gauteng

Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 2004), Sandton, Gauteng

The Oncology Centre ( Site 2000), Durban, Kwazulu-Natal

Cape Town Oncology Trials ( Site 2007), Cape Town, Western Cape

GVI Oncology ( Site 2008), George, Western Cape

Hospital Universitario Virgen de la Victoria ( Site 0878), Malaga, Andalucia

Hospital Universitario Central de Asturias-Medical Oncology ( Site 0870), Oviedo, Asturias

Hospital Son Llatzer ( Site 0886), Palma de Mallorca, Baleares

Hospital Universitari Son Espases-Oncologia ( Site 0883), Palma, Baleares

Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals ( Site 0860), Hospitalet de Llobregat, Barcelona

H. Marques de Valdecilla ( Site 0865), Santander, Cantabria

Institut Catala d Oncologia Hospital Germans Trias i Pujol ( Site 0851), Badalona, Cataluna

Hospital Clinic de Barcelona ( Site 0852), Barcelona, Cataluna

Hospital de la Santa Creu i Sant Pau-Oncología Médica ( Site 0862), Barcelona, Cataluna

CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 0876), Santiago de Compostela, La Coruna

Hospital Universitario Insular de Gran Canaria ( Site 0867), Las Palmas de Gran Canaria, Las Palmas

Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 0877), Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro-Majadahonda ( Site 0861), Majadahonda, Madrid

Hospital Universitario Quiron Madrid ( Site 0868), Pozuelo de Alarcon, Madrid

H.R.U Malaga - Hospital General ( Site 0884), Málaga, Malaga

Hospital Universitari Sant Joan de Reus-Oncology ( Site 0874), Reus, Tarragona

Instituto Valenciano de Oncologia - IVO ( Site 0863), Valencia, Valenciana, Comunitat

Hospital Clinico de Valencia ( Site 0858), Valencia, Valenciana, Comunitat

Hospital General Universitario de Valencia ( Site 0854), Valencia, Valenciana, Comunitat

Hospital Arnau de Vilanova ( Site 0866), Valencia, Valenciana, Comunitat

Hospital Universitari i Politecnic La Fe ( Site 0875), València, Valencia

Hospital General Universitario de Alicante-Oncologia ( Site 0881), Alicante, Not set

Parc de Salut Mar - Hospital del Mar-Oncologia ( Site 0873), Barcelona, Not set

H.U. Vall de Hebron ( Site 0850), Barcelona, Not set

Hospital Universitario Reina Sofia ( Site 0885), Cordoba, Not set

Complejo Hospitalario de Jaén-Servicio de Oncología Médica ( Site 0879), Jaen, Not set

Hospital Universitario Gregorio Maranon ( Site 0864), Madrid, Not set

Clinica Universitaria de Navarra ( Site 0855), Madrid, Not set

Hospital Clinico San Carlos ( Site 0857), Madrid, Not set

Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 0871), Madrid, Not set

Hospital General Universitario 12 de Octubre ( Site 0856), Madrid, Not set

Hospital Universitario La Paz ( Site 0853), Madrid, Not set

Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid, ( Site 0, Madrid, Not set

Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 0880), Sevilla, Not set

HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 0872), Sevilla, Not set

Hospital Universitario Virgen de Valme-Departamento de Oncologia ( Site 0882), Sevilla, Not set

Hospital Clinico Universitario Lozano Blesa ( Site 0859), Zaragoza, Not set

Karolinska Universitetssjukhuset Solna ( Site 0802), Stockholm, Stockholms Lan

Blod och Tumorssjukdomar. Akademiska sjukhuset ( Site 0801), Uppsala, Uppsala Lan

Norrlands Universitetssjukhus ( Site 0800), Umea, Vasterbottens Lan

Sahlgrenska Universitetssjukhuset-Department of Oncology CTU Clinical Trial Unit ( Site 0803), Gothenburg, Vastra Gotalands Lan

University Hospital Basel ( Site 0752), Basel, Basel-Stadt

Hôpitaux Universitaires de Genève (HUG) ( Site 0753), Genève, Geneve

Universitaetsspital Zuerich ( Site 0750), Zürich-Flughafen, Zurich

Kaohsiung Chang Gung Memorial Hospital ( Site 3203), Kaohsiung, Not set

China Medical University Hospital ( Site 3204), Taichung, Not set

National Cheng Kung University Hospital ( Site 3201), Tainan, Not set

National Taiwan University Hospital ( Site 3200), Taipei, Not set

Mackay Memorial Hospital ( Site 3205), Taipei, Not set

Taipei Veterans General Hospital ( Site 3202), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center-Gynecology, Obstetrics, and women's health ( Site 3207), Taipei, Not set

Chang Gung Medical Foundation-Linkou Branch ( Site 3206), Taoyuan, Not set

Chulalongkorn University ( Site 2363), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital ( Site 2364), Bangkok, Krung Thep Maha Nakhon

Faculty of Medicine Siriraj Hospital ( Site 2365), Bangkok, Krung Thep Maha Nakhon

Acibadem Altunizade Hospital-Oncology ( Site 1317), Üsküdar /Istanbul, Istanbul

Acibadem Adana Hospital-Pediatric Hematology-Oncology ( Site 1312), Adana, Not set

Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1307), Adana, Not set

Adana Sehir Egitim ve Arastirma Hastanesi ( Site 1324), Adana, Not set

Ankara University Hospital Cebeci ( Site 1306), Ankara, Not set

Hacettepe Universitesi-oncology hospital ( Site 1304), Ankara, Not set

Ankara City Hospital-Medical Oncology ( Site 1311), Ankara, Not set

Baskent Universitesi Ankara Hastanesi ( Site 1303), Ankara, Not set

Akdeniz Universitesi Hastanesi-Medical Onkology ( Site 1318), Antalya, Not set

Memorial Antalya Hospital-Oncology ( Site 1315), Antalya, Not set

Trakya Universitesi Tip Fakultesi ( Site 1301), Edirne, Not set

Bezmialem Vakf Üniversitesi-Oncology ( Site 1308), Istanbul, Not set

Istanbul University Capa Campus ( Site 1314), Istanbul, Not set

Acibadem Universitesi Atakent Hastanesi ( Site 1319), Istanbul, Not set

Acıbadem Maslak Hastanesi-Medical Oncology ( Site 1321), İstanbul, Not set

Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1302), Istanbul, Not set

TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1316), Istanbul, Not set

Marmara Universitesi Pendik Egitim Arastirma Hastanesi-Medical Oncology ( Site 1305), Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi ( Site 1300), Izmir, Not set

Dokuz Eylul Universitesi Hastanesi ( Site 1323), İzmir, Not set

I.E.U. Medical Point Hastanesi-Oncology ( Site 1310), Izmir, Not set

Kocaeli Üniversitesi ( Site 1313), Kocaeli, Not set

Inonu Universitesi ( Site 1309), Malatya, Not set

Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council ( Site 3650), Dnipro, Dnipropetrovska Oblast

MI Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional-Chemotherapy department ( Site 3657), Kryvyi Rih, Dnipropetrovska Oblast

Communal Non-Commercial Enterprise "Prykarpatski Clinical Oncological Center" of Ivano-Frankivsk Reg, Ivano-Frankivsk, Ivano-Frankivska Oblast

MNPE Regional Center of Oncology ( Site 3665), Kharkiv, Kharkivska Oblast

SO"Grigoriev Inst for Med Radiolgy and Oncology of NAMS of Ukraine" ( Site 3666), Kharlkiv, Kharkivska Oblast

Private Enterprise Private Manufacturing Company Acinus-Medical and Diagnostic Centre ( Site 3656), Kropyvnytskyi, Kirovohradska Oblast

Asklepion Medical Center ( Site 3667), Khodosivka, Kyivska Oblast

National Cancer Institute-Department of Minimally Invasive and Endoscopic Surgery, Interventional R, Kyiv, Kyivska Oblast

Municipal non-profit enterprise "Kyiv City Clinical Oncology Center" of executive body of Kyiv City, Kyiv, Kyivska Oblast

Municipal institution of Lviv regional council Lviv Oncology-Chemotherapy ( Site 3653), Lviv, Lvivska Oblast

Odessa Regional Oncology Center ( Site 3655), Odessa, Odeska Oblast

Sumy regional clinical oncological dispensary-Oncothoracic department ( Site 3661), Sumy, Sumska Oblast

Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council", Vinnytsia, Vinnytska Oblast

Transcarpathian Regional Clinical Oncology Center-Chemotherapy dept. ( Site 3652), Uzhhorod, Zakarpatska Oblast

Municipal non-profit enterprise "Zaporizhzhia regional clinical hospital" of Zaporizhzhia regional c, Zaporizhia, Zaporizka Oblast

Aberdeen Royal Infirmary-Department of Oncology ( Site 0521), Aberdeen, Aberdeen City

Western General Hospital ( Site 0502), Edinburgh, Edinburgh, City Of

The Christie ( Site 0516), Manchester, England

Weston Park Hospital ( Site 0519), Sheffield, England

Mid Essex Hospitals Service Trust. Broomfield Hospital ( Site 0503), Broomfield, Essex

The Beatson West of Scotland Cancer Centre ( Site 0506), Glasgow, Glasgow City

Royal Preston Hospital ( Site 0518), Preston, Lancashire

Barts Health NHS Trust ( Site 0512), London, London, City Of

University College London Hospital-Cancer Clinical Trials Unit ( Site 0520), London, London, City Of

Royal Free Hospital ( Site 0507), London, London, City Of

Royal Marsden Hospital ( Site 0505), London, London, City Of

Sarah Cannon Research UK ( Site 0504), London, London, City Of

Belfast City Hospital ( Site 0508), Belfast, Northern Ireland

Nottingham University Hospitals NHS Trust ( Site 0510), Nottingham, Nottinghamshire

St James University Hospital ( Site 0509), Leeds, Not set

The Royal Marsden NHS Foundation Trust. ( Site 0513), Sutton, Not set

New Cross Hospital-Department of Oncology ( Site 0517), Wolverhampton, Not set

Conditions: Solid Tumors, Hematologic Malignancies

Learn More ›

QTX3034 in Patients With KRAS G12D Mutation

NCT06227377

Recruiting

Phase 1 study to determine the safety and tolerability of QTX3034 as a single agent or in combination with cetuximab.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Sarah Cannon Research Institute (SCRI), Denver, Colorado +12 locations

Conditions: Solid Tumors

Learn More ›

A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)

NCT05155332

Recruiting

This study is open to adults with different types of advanced cancer (solid tumors) that are accessible for injection and/or biopsy. This is a study for people with a life expectancy of at least 3 months after starting study treatment. The purpose of this study is to find the highest dose of a medicine called BI 1831169 that people with advanced cancer can tolerate when taken with or without a type of antibody called a checkpoint inhibitor (anti-PD-1 antibody). Another purpose is to check whethe... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/14/2025

Locations: Banner MD Anderson Cancer Center-Gilbert-55251, Gilbert, Arizona +31 locations

Banner MD Anderson Cancer Center-Gilbert-55251, Gilbert, Arizona

University of Arizona, Tucson, Arizona

University of California Irvine, Orange, California

Providence St. John's Health Center, Santa Monica, California

University of Colorado Denver, Aurora, Colorado

University of Louisville, Louisville, Kentucky

M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota

Morristown Medical Center, Morristown, New Jersey

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina

The University of Texas MD Anderson Cancer Center, Houston, Texas

Southern Oncology Clinical Research Unit, Bedford Park, South Australia

Peninsula Haematology & Oncology, Frankston, Victoria

Medical University of Innsbruck, Innsbruck, Not set

Edegem - UNIV UZ Antwerpen, Edegem, Not set

UNIV UZ Gent, Gent, Not set

UZ Leuven, Leuven, Not set

INS Bergonie, Bordeaux, Not set

HOP Timone, Marseille, Not set

CTR Eugène Marquis, Rennes, Not set

INS Gustave Roussy, Villejuif, Not set

Charite Universitätsmedizin Berlin KöR, Berlin, Not set

Universitätsklinikum Heidelberg, Heidelkberg, Not set

Universitätsklinikum Tübingen, Tübingen, Not set

Universitätsklinikum Ulm, Ulm, Not set

ASST Grande Ospedale Metropolitano Niguarda, Milano, Not set

Azienda Ospedaliera Universitaria Integrata Verona, Verona, Not set

Hospital Duran i Reynals, L'Hospitalet de Llobregat, Not set

Fundación Jiménez Díaz, Madrid, Not set

Clínica Universidad de Navarra, Pamplona, Not set

Instituto Valenciano de Oncología, Valencia, Not set

University Hospital Bern/Inselspital Bern, Bern, Not set

University Hospital Geneva, Geneve, Not set

Conditions: Solid Tumors

Learn More ›

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Recruiting

The objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with locally advanced or metastatic solid tumors, or recurrent or progressive primary central nervous system (CNS) tumors harboring BRAF fusions, or in participants with rare BRAF V600-mutated solid tumors, melanoma, thyroid, or recurrent primary CNS tumors.

Gender:

ALL

Ages:

10 years and above

Trial Updated:

04/14/2025

Locations: UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California +54 locations

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

University of California Los Angeles Rheumatology, Westwood, California

University of Miami Hospital and Clinics, Miami, Florida

The John Hopkins Hospital, Baltimore, Maryland

Maryland Oncology Hematology- Columbia, Rockville, Maryland

Tufts Medical Center, Boston, Massachusetts

St. Luke's Hospital, Duluth, Minnesota

Mosaic Life Care at Saint Joseph - Medical Center, Saint Joseph, Missouri

Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha, Nebraska

Overlook Medical Center, Summit, New Jersey

Columbia University Irving Medical Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Nationwide Children's Hospital, Columbus, Ohio

Taylor Cancer Research Center, Maumee, Ohio

Toledo Clinic Cancer Center, Toledo, Ohio

Thomas Jefferson University, Philadelphia, Pennsylvania

Lifespan Cancer Institute - Rhode Island Hospital, Providence, Rhode Island

Baylor Scott & White Research Institute, Dallas, Texas

Baylor Scott & White Medical Center, Temple, Texas

University of Washington School of Medicine, Seattle, Washington

West Virginia University Health Sciences Campus, Morgantown, West Virginia

The Alfred, Melbourne, Victoria

Sydney Children's Hospital Network - Randwick, Randwick, Not set

Sunny brook Health Sciences Centre- Bayview Campus, Toronto, Ontario

Centre Hospitalier Universitaire Sainte-Justine, Montréal, Quebec

Institut Bergonie, Bordeaux Cedex, Aquitaine

Hôpital Nord de Marseille, Marseille, Bouches-du-Rhône

Hôpital Morvan, Brest, Finistère

Hôpital Universitaire Pitié Salpêtrière, Paris, Ile-de-France

Institut de Cancerologie de l'Ouest- Angers, Angers, Pays De La Loire

Gustave Roussy, Villejuif, Val-de-Marne

Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, Not set

Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg

Krankenhaus Nordwest, Frankfurt, Hessen

Charité - Universitätsmedizin Berlin, Berlin, Not set

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST, Meldola, Forli-Cesena

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Naples

Istituto Europeo di Oncologia, Milano, Not set

Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele, Milan, Not set

Catholic University of Korea Saint Vincent's Hospital, Suwon-si, Gyeonggi-do

Seoul National University Hospital, Suwon, Gyeonggido

Dong-A University Hospital, Busan, Gyeongsangnam-do

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do

Seoul National University Hospital, Seoul, Seoul Teugbyeoisi

Severance Hospital, Seoul, Seoul Teugbyeolsi

Hospital Clinico Universitarlo de Santiago, Santiago De Compostela, A Coruña

Hospital Clinico Universitarlo de Valencia, València, Valencia

Hospital Universitari Vall d'Hebron, Barcelona, Not set

Hospital Infantil Universitario Niño Jesús, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario Virgen del Rocío, Sevilla, Not set

Skånes Universitetssjukhus, Lund, Skåne Län

Karolinska Universitetssjukhuset, Solna, Stockholms Län

The Christie NHS Foundation Trust, Manchester, England

Sarah Cannon Research Institute, London, Not set

Conditions: Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors, Melanoma BRAF V600E/K Mutated, Thyroid Cancer

Learn More ›

A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06818812

Recruiting

The purpose of this study is to evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: UCLA Healthcare Hematology-Oncology, Santa Monica, California +8 locations

Conditions: Solid Tumors

Learn More ›

5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

NCT03366116

Recruiting

Background: Blood, tissue, and tumor cells contain genes. Genes are made up of DNA. DNA is the instruction book for each cell. In some people with cancer, the genes that might have slowed the growth of their tumor were turned off. Researchers want to see if a new drug can turn the genes back on and slow the tumor growth. The drug is called Aza-TdC. Objective: To test the safety of Aza-TdC, and to find out the dose of this drug that can be safely given to humans. Eligibility: People ages 18... Read More

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

04/10/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Neoplasms, Solid Tumors

Learn More ›

1 - 12 of 43